EMEA-001270-PIP01-12-M01

Key facts

Invented name
Orbactiv
Active substance
Oritavancin (diphosphate)
Therapeutic area
Infectious diseases
Decision number
P/0096/2017
PIP number
EMEA-001270-PIP01-12-M01
Pharmaceutical form(s)
  • Powder for solution for injection
  • Age-appropriate dosage form for parenteral use
Condition(s) / indication(s)
Treatment of skin and subcutaneous-tissue bacterial infections
Route(s) of administration
Intravenous use
Contact for public enquiries
Rempex London Ltd

Tel. +1 908 723 9513

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating